Lindbrook Capital’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Lindbrook Capital’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-100	Closed	-$6K	–	1867
2020 Q2	$6K	Buy	+100	New	+$9.16K	﹤0.01%	1052
2020 Q1	–	Sell	-350	Closed	-$48K	–	1891
2019 Q4	$48K	Buy	350 +100	+40%	+$12.2K	0.02%	460
2019 Q3	$30K	Sell	250 -50	-17%	-$6.98K	0.01%	579
2019 Q2	$41K	Hold	300	–	–	0.02%	480
2019 Q1	$53K	Buy	+300	New	+$45.1K	0.02%	391

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Lindbrook Capital's ORTX Position: Q3 2020 in Review

Lindbrook Capital sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2020, closing a stake of 100 shares — an estimated $6K sold.

Lindbrook Capital first reported a position in ORTX in Q1 2019 and held it in 5 quarters. The position peaked at $53K in Q1 2019. 72 funds tracked by Wall St. Rank hold ORTX as of Q3 2020.

Lindbrook Capital reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Lindbrook Capital sold 100 Orchard Therapeutics plc American Depositary Shares shares in Q3 2020, an estimated $6K.
Lindbrook Capital first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2019 and held it in 5 quarters.
Lindbrook Capital's Orchard Therapeutics plc American Depositary Shares position peaked at $53K in Q1 2019.
72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2020.

Based on Lindbrook Capital's 13F filing for Q3 2020, filed 3 Nov 2020.